Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VVUS: VIVUS INC. (NASDAQ) -- Ignore unavailable to you. Want to Upgrade?

To: Frostman who wrote (22512)	9/25/1999 11:13:00 PM
From: Greg22	Read Replies (2) \| Respond to of 23519

Frostman, Alibra is going to be interesting. I might be overly optimistic here, but this drug is undervalued by the street. I think that most doctors will be willing to recommend Alibra to their patients for the safety profile. Even though Muse is a good product, the problems with it are titration, dosing, storage, and insertion into the urethra. Alibra will solve 3 of the 4. Taking our comparison to the next level, the advantages and disadvantages of Alibra v. Viagra would be: Alibra advantages: 1.) Safety! 2.) Higher efficacy rate v. Viagra, and v. Muse. 3.) On demand response. 4.) Lesser side effects(?) Alibra disadvantages: 1.) Administration - involves insertion into urethra, but greatly improved over Muse since no titration, dosing, or refrigeration. Now, what's wrong with this picture?